Workflow
enVista
icon
Search documents
BAUSCH & LOMB ALERT: Bragar Eagel & Squire, P.C. is Investigating Bausch + Lomb Corporation on Behalf of Bausch & Lomb Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-06-27 01:00
Core Viewpoint - Bausch + Lomb Corporation is under investigation for potential violations of federal securities laws and unlawful business practices following a product recall and subsequent stock price drop [1][2]. Group 1: Product Recall and Impact - On March 27, 2025, Bausch + Lomb announced a voluntary recall of intraocular lenses from its enVista platform due to reports of toxic anterior segment syndrome (TASS), which is a complication associated with cataract surgery [2]. - The recall has raised short-term concerns regarding product safety and may lead to increased regulatory scrutiny [2]. - Following the recall announcement, Bausch + Lomb's stock price fell by $1.50 per share, representing a 10.6% decrease, closing at $15.00 on the same day [2]. Group 2: Legal Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims against Bausch + Lomb on behalf of its stockholders, focusing on possible violations of federal securities laws [1]. - The law firm is reaching out to long-term stockholders who may have suffered losses or have information related to the claims [3].
BLCO Investors Have Opportunity to Join Bausch + Lomb Corporation Fraud Investigation with the Schall Law Firm
Prnewswire· 2025-06-11 14:02
Core Viewpoint - The Schall Law Firm is investigating Bausch + Lomb Corporation for potential violations of securities laws, focusing on misleading statements and undisclosed information that may have affected investors [1][2]. Financial Performance - Bausch + Lomb reported an adjusted net loss of $54 million for Q1 2025, a significant decline compared to a net income of $24 million in the same period of the previous year [2]. - The company has lowered its full-year growth outlook, attributing part of this change to the recall of its enVista product [2].
获批CE!博士伦全视程预装人工晶状体
思宇MedTech· 2025-05-21 08:16
2025年7月17日,第二届全球医疗科技大会 2025年9月4-5日,第三届全球手术机器人大会 近日, 博士伦 宣布,其 LuxLife全视程人工晶状体 (IOL) 获得了CE认证 。这是一款 预装式人工晶状体 , 核 心亮点在于搭载了纯折射光学(PRO)技术和联合射线(ART)技术,能够提供从远距离到近距离的自然、连续 视力。 思宇年度活动回顾: 首届全球眼科大会 | 首届全球骨科大会 | 首届全球心血管大会 即将召开: 2025年6月12日,首届全球医美科技大会 LuxLife IOL 的核心技术包括纯折射光学(PRO)技术和联合射线(ART)技术。 纯折射光学(PRO)技术 LuxLife IOL 采用纯折射光学(PRO)技术 ,这种技术的核心在于其光学设计完全基于折射原理。通过精确设计 其光学表面的形状和曲率,使得光线在经过晶状体时能够被连续、均匀地折射,从而在整个光学直径范围内形成 一个不间断的连续折射表面。 与传统的衍射型人工晶状体相比,纯折射光学技术避免了因衍射效应而导致的光线损失。 联合射线(ART)技术 LuxLife IOL 拥有两个独特的联合射线技术(ART)区域, 这些区域通过特殊的光 ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
GlobeNewswire News Room· 2025-05-13 16:17
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation (“Bausch + Lomb” or the “Company”) (NYSE: BLCO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Bausch + Lomb and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
Prnewswire· 2025-05-06 18:04
NEW YORK, May 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation ("Bausch + Lomb" or the "Company") (NYSE: BLCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether Bausch + Lomb and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action]On March ...
GM Trims Outlook, Halts Buyback Amid Tariffs: Sell the Stock Now?
ZACKS· 2025-05-02 13:50
Core Viewpoint - General Motors (GM) has revised its 2025 earnings forecast downward due to potential new U.S. auto tariffs, estimating a cost impact of $4-$5 billion [1][3][4]. Financial Outlook - GM now expects adjusted EBIT for 2025 to be between $10 billion and $12.5 billion, down from a previous range of $13.7 billion to $15.7 billion [4]. - Net income attributable to shareholders is projected to fall to between $8.2 billion and $10.1 billion, compared to earlier guidance of $11.2 billion to $12.5 billion [4]. - Adjusted automotive free cash flow is now expected to be in the range of $7.5 billion to $10 billion, lower than the previous forecast of $11 billion to $13 billion [4]. Impact of Tariffs - A significant factor in the downward revision is a projected $2 billion business hit from South Korea, where several key models are assembled [5]. - GM's CEO has indicated that tariff-related challenges will create significant disruption in the auto industry [2]. Stock Buyback and Analyst Revisions - GM has temporarily suspended its share buyback program until there is more clarity on the tariff impact, with $4.3 billion in repurchase capacity remaining [6]. - Analysts have begun to lower their EPS forecasts for GM for 2025, with further cuts anticipated [6]. Tariff Defense Strategy - GM aims to offset up to 30% of expected tariff-related costs through "self-help initiatives," including increasing U.S.-based vehicle and battery production [7]. - The company has increased its U.S. direct purchases by 27% since 2019, with over 80% of U.S.-built vehicle content meeting USMCA standards [8]. Market Performance - Year-to-date, GM shares have declined by 15%, which is better than Harley-Davidson's 23% drop, while Ford has seen a 2.8% increase [10]. - GM's stock trades at a forward price-to-sales (P/S) ratio of 0.25, significantly below the industry average of 2.19, indicating it may be undervalued [13]. Long-term Strategy - GM is progressing with its long-term electric vehicle (EV) strategy, being the 2 EV seller in the U.S. and achieving variable profit positive status for its EV lineup by late 2024 [16]. - The company ended the first quarter with $20.7 billion in cash and cash equivalents, indicating solid financial health [17].
美国中产消费信心暴跌,麦当劳、好时、哈雷摩托车等销售已受冲击
Hua Er Jie Jian Wen· 2025-05-02 01:22
Group 1: Consumer Sentiment and Spending - The Trump tariff policy has severely impacted consumer confidence in the U.S., particularly among middle and low-income groups, leading to reduced spending [1] - Companies that primarily target middle-class consumers, such as McDonald's, General Motors, Harley-Davidson, and Hershey, are experiencing declining sales and profit pressures [1] - McDonald's reported its lowest sales in mature U.S. restaurants since the pandemic, attributing this to cautious spending by lower-income customers [1] Group 2: Automotive Industry Impact - Harley-Davidson's motorcycle sales fell by 24% year-over-year, with the CEO citing economic uncertainty and high interest rates as key factors [2] - General Motors, despite initial sales growth, has lowered its annual profit forecast by $2 billion to $3 billion due to tariff costs of $4 billion to $5 billion [2] - GM plans to increase North American prices by up to 1%, reversing an earlier expectation of a price decrease [2] Group 3: Confectionery Sector Challenges - Hershey reported a 15% decline in sales of candy, mints, and gum, with executives noting a growing consumer focus on value [3] - The company anticipates a loss of $15 million to $20 million in the current quarter due to tariffs on key raw materials like cocoa, which cannot be grown domestically [3] Group 4: Technology Sector Performance - Apple reported strong second-quarter sales driven by increased iPhone demand, potentially due to panic buying before new tariffs took effect [4] - Analysts warn that ongoing economic uncertainty poses real risks to both domestic and global economies, with signs of declining business and consumer confidence [4]